Species : |
Human |
Source : |
CHO |
Protein Length : |
17-410 a.a. |
Description : |
This gene encodes a member of the serpin superfamily of serine proteinase inhibitors. The protein is primarily secreted by axons in the brain, and preferentially reacts with and inhibits tissue-type plasminogen activator. It is thought to play a role in the regulation of axonal growth and the development of synaptic plasticity. Mutations in this gene result in familial encephalopathy with neuroserpin inclusion bodies (FENIB), which is a dominantly inherited form of familial encephalopathy and epilepsy characterized by the accumulation of mutant neuroserpin polymers. Multiple alternatively spliced variants, encoding the same protein, have been identified. |
Bio-activity : |
ED50 < 2.0 μg/mL, measured by the dose-dependent stimulation of the proliferation of rat C6 cells, corresponding to a specific activity of > 500.0 units/mg. |
Molecular Mass : |
40~45 kDa, on SDS-PAGE under non-reducing conditions. |
Endotoxin : |
< 0.2 EU/ μg of protein by gel clotting method |
Purity : |
> 95% as analyzed by SDS-PAGE > 95% as analyzed by HPLC |
Storage : |
Upon receiving, this product remains stable for up to 6 months at lower than -70 centigrade. Upon reconstitution, the product should be stable for up to 1 week at 4 centigrade or up to 3 months at -20 centigrade. For long term storage it is recommended that a carrier protein (example 0.1% BSA) be added. Avoid repeated freeze-thaw cycles. |
Storage Buffer : |
Lyophilized after extensive dialysis against PBS. |
Reconstitution : |
It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in ddH2O or PBS up to 100 μg/mL. |